New eye injection aims to tackle Diabetes-Related vision loss
Disease control
Recruiting now
This study tests an experimental drug called THN391, given as an injection into the eye, for people with diabetic macular edema (DME) — a condition where fluid builds up in the retina due to diabetes, causing vision loss. The trial involves 21 adults aged 18 to 80 with DME and vi…
Phase: PHASE1 • Sponsor: Therini Bio Pty Ltd • Aim: Disease control
Last updated Jul 03, 2026 20:42 UTC